Trial Profile
Study on the Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Tenofovir
- Indications Hepatitis B
- Focus Therapeutic Use
- 27 Nov 2018 New trial record